T80.82XS Abrechenbarer, spezifischer Code Complication of immune effector cellular therapy, sequela

ICD-10-CM T80.82XS identifies “Complication of immune effector cellular therapy, sequela” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Kapitel 19: Injury, poisoning and certain other consequences of external causes

Von der Angabe „bei Aufnahme vorhanden“ ausgenommen

Hinweise zum Code

Keine zusätzlichen Hinweise.

Hinweise übergeordneter Ebenen

Kapitel 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)

Excludes 22
  • birth trauma (P10-P15)
  • obstetric trauma (O70-O71)
Use additional code1

code to identify any retained foreign body, if applicable (Z18.-)

Note2
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

T80-T88 · Complications of surgical and medical care, not elsewhere classified (T80-T88)

Excludes 221
  • any encounters with medical care for postprocedural conditions in which no complications are present, such as:
  • artificial opening status (Z93.-)
  • closure of external stoma (Z43.-)
  • fitting and adjustment of external prosthetic device (Z44.-)
  • burns and corrosions from local applications and irradiation (T20-T32)
  • complications of surgical procedures during pregnancy, childbirth and the puerperium (O00-O9A)
  • mechanical complication of respirator [ventilator] (J95.850)
  • poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)
  • postprocedural fever (R50.82)
  • specified complications classified elsewhere, such as:
  • cerebrospinal fluid leak from spinal puncture (G97.0)
  • colostomy malfunction (K94.0-)
  • disorders of fluid and electrolyte imbalance (E86-E87)
  • functional disturbances following cardiac surgery (I97.0-I97.1)
  • intraoperative and postprocedural complications of specified body systems (D78.-, E36.-, E89.-, G97.3-, G97.4, H59.3-, H59.-, H95.2-, H95.3, I97.4-, I97.5, J95.6-, J95.7, K91.6-, L76.-, M96.-, N99.-)
  • ostomy complications (J95.0-, K94.-, N99.5-)
  • postgastric surgery syndromes (K91.1)
  • postlaminectomy syndrome NEC (M96.1)
  • postmastectomy lymphedema syndrome (I97.2)
  • postsurgical blind-loop syndrome (K91.2)
  • ventilator associated pneumonia (J95.851)
Use additional code3
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code(s) to identify the specified condition resulting from the complication
  • code to identify devices involved and details of circumstances (Y62-Y82)

T80.82 · Complication of immune effector cellular therapy

Inclusion terms2
  • Complication of chimeric antigen receptor (CAR-T) cell therapy
  • Complication of IEC therapy
Excludes 23
  • adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
  • complication of bone marrow transplant (T86.0)
  • complication of stem cell transplant (T86.5)
Use additional code3
  • code to identify the specific complication, such as:
  • cytokine release syndrome (D89.83-)
  • immune effector cell-associated neurotoxicity syndrome (G92.0-)

T80 · Complications following infusion, transfusion and therapeutic injection

Includes1

complications following perfusion

Excludes 27
  • bone marrow transplant rejection (T86.01)
  • febrile nonhemolytic transfusion reaction (R50.84)
  • fluid overload due to transfusion (E87.71)
  • posttransfusion purpura (D69.51)
  • transfusion associated circulatory overload (TACO) (E87.71)
  • transfusion (red blood cell) associated hemochromatosis (E83.111)
  • transfusion related acute lung injury (TRALI) (J95.84)
Seventh character1

The appropriate 7th character is to be added to each code from category T80

A — initial encounter

D — subsequent encounter

S — sequela

Verweise im offiziellen Index

Offizielle Konversionshistorie

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Gültigkeitszeitraum 2021-10-01

Frühere Zuordnung: T80.89XS

Verlauf

Codeverlauf

Letzte erfasste Änderung · FY2025 · 04-01

GeändertUnverändert
FY2025 · 04-01

Gültig ab

  • Übergeordnete Hinweise geändert

Complication of immune effector cellular therapy, sequela

Abrechenbarer Diagnosecode

CDC/NCHS · FY2025 · 04-01

Alle Ausgaben (11)

Alle AusgabenGültig abCodeverlauf
FY20222021-10-01Hinzugefügt
FY2022 · 04-012022-04-01Keine tabellarische Änderung
FY20232022-10-01Keine tabellarische Änderung
FY2023 · 04-012023-04-01Keine tabellarische Änderung
FY20242023-10-01Keine tabellarische Änderung
FY2024 · 04-012024-04-01Keine tabellarische Änderung
FY20252024-10-01Übergeordnete Hinweise geändert
FY2025 · 04-012025-04-01Übergeordnete Hinweise geändert
FY20262025-10-01Keine tabellarische Änderung
FY2026 · April2026-04-01Keine tabellarische Änderung
FY20272026-10-01Keine tabellarische Änderung

Dieser Eintrag ist ein vollständiger Code in der gewählten Ausgabe. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.